//A risk-based approach to optimize autologous hematopoietic stem cell (HSC) collection with the use of plerixafor

A risk-based approach to optimize autologous hematopoietic stem cell (HSC) collection with the use of plerixafor

2018-04-11T05:48:25+00:00